DOSE DENSE ABVD (DD‐ABVD) AS FIRST LINE THERAPY IN EARLY‐STAGE UNFAVORABLE HODGKIN LYMPHOMA (HD): RESULTS OF A PHASE II, PROSPECTIVE STUDY BY FONDAZIONE ITALIANA LINFOMI. (12th June 2019) - Mazza, R.; Spina, M.; Califano, C.; Gaudio, F.; Carella, M.; Consoli, U.; Palombi, F.; Musso, M.; Pulsoni, A.; Kovalchuk, S.; Bonfichi, M.; Ricci, F.; et al.